257 related articles for article (PubMed ID: 23160182)
1. Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo.
Kundu S; Roome T; Bhattacharjee A; Carnevale KA; Yakubenko VP; Zhang R; Hwang SH; Hammock BD; Cathcart MK
J Lipid Res; 2013 Feb; 54(2):436-47. PubMed ID: 23160182
[TBL] [Abstract][Full Text] [Related]
2. Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1.
Carnevale KA; Cathcart MK
J Immunol; 2001 Sep; 167(6):3414-21. PubMed ID: 11544333
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.
Sanders WG; Morisseau C; Hammock BD; Cheung AK; Terry CM
Am J Physiol Cell Physiol; 2012 Aug; 303(3):C278-90. PubMed ID: 22621785
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.
Liu JY; Yang J; Inceoglu B; Qiu H; Ulu A; Hwang SH; Chiamvimonvat N; Hammock BD
Biochem Pharmacol; 2010 Mar; 79(6):880-7. PubMed ID: 19896470
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
7. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.
Jung O; Jansen F; Mieth A; Barbosa-Sicard E; Pliquett RU; Babelova A; Morisseau C; Hwang SH; Tsai C; Hammock BD; Schaefer L; Geisslinger G; Amann K; Brandes RP
PLoS One; 2010 Aug; 5(8):e11979. PubMed ID: 20694143
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic acid pathway in human health and diseases.
Bellien J; Joannides R
J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK.
Luo Y; Wu MY; Deng BQ; Huang J; Hwang SH; Li MY; Zhou CY; Zhang QY; Yu HB; Zhao DK; Zhang G; Qin L; Peng A; Hammock BD; Liu JY
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5154-5159. PubMed ID: 30804206
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
[TBL] [Abstract][Full Text] [Related]
12. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report.
Shao Z; Fu Z; Stahl A; Joyal JS; Hatton C; Juan A; Hurst C; Evans L; Cui Z; Pei D; Gong Y; Xu D; Tian K; Bogardus H; Edin ML; Lih F; Sapieha P; Chen J; Panigrahy D; Hellstrom A; Zeldin DC; Smith LE
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):581-6. PubMed ID: 24458713
[TBL] [Abstract][Full Text] [Related]
14. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of ascorbate direct modulation of soluble epoxide hydrolase.
Zhang B; Kandhi S; Yang YM; Le Y; Deng W; Qin J; Jiang H; Froogh G; Sun D; Huang A
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():59-66. PubMed ID: 28827137
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.
Sun CP; Zhang XY; Morisseau C; Hwang SH; Zhang ZJ; Hammock BD; Ma XC
J Med Chem; 2021 Jan; 64(1):184-215. PubMed ID: 33369424
[TBL] [Abstract][Full Text] [Related]
17. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
Gurung AB; Mayengbam B; Bhattacharjee A
Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
[TBL] [Abstract][Full Text] [Related]
19. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
20. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
Katary MM; Pye C; Elmarakby AA
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
